Rituximab in Idiopathic Pulmonary Hemosiderosis in Children: A Novel and Less Toxic Treatment Option.

Terheggen-Lagro, Suzanne W J; Haarman, Eric G; Rutjes, Niels W; van den Berg, J Merlijn; Schonenberg-Meinema, Dieneke

Terheggen-Lagro, Suzanne W J; Haarman, Eric G; Rutjes, Niels W; van den Berg, J Merlijn; Schonenberg-Meinema, Dieneke.

Afiliação

Terheggen-Lagro SWJ; Department of Pediatric Pulmonology and Allergy, Amsterdam University Medical Centres, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Haarman EG; Department of Pediatric Pulmonology and Allergy, Amsterdam University Medical Centres, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Rutjes NW; Department of Pediatric Pulmonology and Allergy, Amsterdam University Medical Centres, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
van den Berg JM; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Amsterdam University Medical Centres, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Schonenberg-Meinema D; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Amsterdam University Medical Centres, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Pharmaceuticals (Basel) ; 15(12)2022 Dec 13.

Article em En | MEDLINE | ID: mdl-36559000

Palavras-chave

pediatric; pulmonary bleeding; pulmonary hemosiderosis; rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google